Oracle Corp Form 4 Filings

ORACLE CORP (ORCL) Chief Executive Officer Michael D. Sicilia reported several equity transactions. On September 16, 2026, he sold 10,882 shares of common stock at $139.94 per share pursuant to a Rule 10b5-1 Plan adopted on December 24, 2025. On September 15, 2026, 52,673 restricted stock units converted into the same number of common shares, and 25,468 shares were withheld to cover tax liability on vesting. He also reports 2,655 shares of common stock held indirectly by his spouse and 52,674 restricted stock units remaining after these transactions.

Oracle Corp (ORCL) reported that its Chief Executive Officer, Clayton M. Magouyrk, had restricted stock units vest on September 15, 2026, converting 61,452 RSUs into an equal number of common shares. In connection with this vesting, 24,182 shares were withheld to pay tax liabilities, and the filing shows 61,453 restricted stock units remaining outstanding. No transactions were made under a Rule 10b5-1 trading plan.

ORACLE CORP (ORCL) reported that executive vice president and chief legal officer Stuart Levey exercised and settled 26,337 Restricted Stock Units into an equal number of Oracle common shares on September 15, 2026. Of these, 11,883 shares were withheld to satisfy tax liability at $144.79 per share; no Rule 10b5-1 trading plan is indicated.

ORACLE CORP (ORCL) reported that Mark Hura, President, Global Field Operations, had restricted stock units vest on September 15, 2026, resulting in the issuance of 28,531 shares of common stock. Of these, 12,440 shares were withheld at $144.79 per share to cover tax liability, and 28,532 restricted stock units remain outstanding, vesting in four equal annual installments. No Rule 10b5-1 trading plan is reported.

ORACLE CORP (ORCL) director and vice chairman Jeffrey Henley reported the vesting and conversion of 19,752 Restricted Stock Units into an equal number of shares of common stock on September 15, 2026, held indirectly by a trust. In connection with this vesting, 8,635 shares were withheld by the trust to pay tax liabilities at $144.79 per share. Following these transactions, Henley also reports indirect holdings of 745,000 shares of common stock held by a GRAT and 490,333 shares held by the Henley Community Property Trust; no Rule 10b5-1 plan is reported.

Oracle executive Stuart Levey, EVP and Chief Legal Officer, received an award of 523.382 restricted stock unit dividend equivalents on July 24, 2026. These relate to earned restricted stock units granted on November 5, 2022 and were calculated using Oracle’s $114.99 closing stock price on that dividend payment date.

After this compensation-related acquisition, Levey directly holds 160,364.685 Oracle common stock equivalents.

Oracle Corp vice chairman Jeffrey Henley reported an exercise-and-sell transaction in Oracle common stock. On June 24, 2026, he exercised stock options to acquire 400,000 shares at an exercise price of $40.93 per share pursuant to a Rule 10b5-1 plan adopted on January 2, 2026.

The same day, he sold 400,000 shares in multiple open-market trades at weighted average prices ranging from about $155.50 to $165.57, also under that pre-arranged Rule 10b5-1 plan. After these transactions, he held 325,031 Oracle shares directly.

Henley also reported significant indirect ownership, including 490,333 Oracle shares held by the Henley Community Property Trust, 455,910 shares held by a trust, and 745,000 shares held by a GRAT, showing that a large portion of his overall exposure remains in indirect vehicles.

RUSCKOWSKI STEPHEN H reported acquisition or exercise transactions in this Form 4 filing.

Oracle Corp director Stephen H. Rusckowski received a grant of 1,550 restricted stock units. Each unit represents the right to receive one share of Oracle common stock at settlement. The restricted stock units vest 100% on the first anniversary of the grant date.

After this compensation-related award, Rusckowski holds 1,550 restricted stock units directly, with no open-market purchases or sales reported in this filing.

Oracle director Charles W. Moorman reported routine equity compensation activity. He exercised 2,114 restricted stock units, receiving the same number of Oracle common shares at a stated price of $0.0000 per share, and now holds 40,689 common shares directly.

He also received a new grant of 1,550 restricted stock units, each representing one future share of common stock, which vest 100% on the first anniversary of the grant date. In addition, he is shown with 52,954 common shares held indirectly through multiple family trusts, reflecting indirect ownership rather than a new market trade.

Mihaljevic Tomislav reported acquisition or exercise transactions in this Form 4 filing.

Oracle Corp director Tomislav Mihaljevic received a grant of 1,550 restricted stock units (RSUs). Each RSU represents the right to receive one share of Oracle common stock at settlement. The RSUs vest 100% on the first anniversary of the grant date, and this award brings his reported RSU holdings to 1,550 units held directly.

Oracle director Rona Fairhead reported routine equity compensation activity involving restricted stock units. On May 31, 2026, 2,114 restricted stock units were converted into 2,114 shares of Oracle common stock, and 58 shares were withheld at $225.78 per share to cover tax liabilities on vesting.

She also received a grant of 1,550 new restricted stock units, which vest 100% on the first anniversary of the grant date. Following these transactions, Fairhead directly holds 24,166 shares of Oracle common stock, in addition to indirect holdings for three children of 3,861, 3,720, and 3,694 shares, respectively.

Oracle Corp director Bruce R. Chizen reported routine equity compensation activity with no open-market trades. He exercised 2,114 restricted stock units into 2,114 shares of common stock, increasing his directly held common stock to 71,056 shares. He also received a new grant of 1,550 restricted stock units, each representing the right to receive one share of common stock at settlement and scheduled to vest 100% on the first anniversary of the grant date. In addition, 13,169 shares of common stock are reported as held indirectly through a trust.

Oracle director Michael J. Boskin reported routine equity compensation activity. He exercised restricted stock units covering 2,114 shares of Oracle common stock, bringing his directly held common stock to 97,558 shares. He also received a new grant of 1,550 restricted stock units, which each convert into one share and vest 100% on the first anniversary of the grant date. In addition, 1,000 shares of common stock are reported as held indirectly through his spouse.

Oracle Corp director Jeffrey Berg reported routine equity compensation changes. He exercised 2,114 restricted stock units, which converted into 2,114 shares of Oracle common stock held indirectly through The Berg Family Trust, bringing that trust’s indirect common stock holdings to 154,113 shares.

He also received a new grant of 1,550 restricted stock units, all held directly, each representing one future share of common stock at settlement. The filing notes an additional indirect holding of 1,450 common shares held by his spouse and includes a correction to previously reported indirect beneficial ownership from an earlier Form 4.

Oracle Corp director Ablo Awo reported routine equity compensation activity involving restricted stock units. On May 31, 2026, 2,114 restricted stock units were exercised into the same number of common shares, and 80 shares of common stock were withheld at $225.78 per share to cover tax obligations.

On the same date, Awo also received a new grant of 1,550 restricted stock units, each representing the right to receive one share of Oracle common stock at settlement. These units vest 100% on the first anniversary of the grant date, reflecting standard time-based vesting rather than an open-market transaction.

Oracle Corporation Chief Financial Officer Hilary B. Maxson received new equity awards. On May 5, 2026, she was granted 56,111 restricted stock units and stock options on 224,441 shares of common stock at an exercise price of $185.35 per share.

The stock options vest 40% on May 5, 2027, 30% on May 5, 2028, 20% on May 5, 2029, and 10% on May 5, 2030, and expire on May 5, 2036, subject to continued employment through each vesting date. The restricted stock units follow the same 40/30/20/10 vesting schedule and each unit represents the right to receive one share of common stock at settlement.

Oracle Corporation executive vice president and chief legal officer Stuart Levey acquired 346.321 restricted stock units in the form of dividend equivalents tied to previously earned RSUs granted on November 5, 2022. The dividend equivalents were calculated using Oracle’s closing stock price of $173.28 on April 24, 2026, and increase his directly held equity-based position to 159,841.303 units of common-stock-settled awards. This is a compensation-related grant, not an open‑market trade.

ORACLE CORP executive vice president and chief legal officer Stuart Levey reported an open-market sale of 15,000 shares of Oracle common stock at an average price of $176.19 per share. After this transaction, he directly holds 3,429 shares. The sale was executed pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on January 13, 2026, indicating it was scheduled in advance rather than timed discretionarily.

Oracle Corp vice chairman Jeffrey Henley reported an internal restructuring of his indirect Oracle common stock holdings. On April 16, 2026, 745,000 shares were transferred from the Jeffrey & Judy Henley 1989 Trust to a newly created grantor retained annuity trust, both entities associated with him as trustee, with no cash consideration. Following the transactions, indirect holdings reported include 455,910 shares by the 1989 Trust, 745,000 shares by the new GRAT, and 490,333 shares by the Henley Community Property Trust, reflecting estate-planning movements rather than open‑market trading.

Oracle Corp director and vice chairman Jeffrey Henley reported indirect share transfers involving family trusts. On March 30, 2026, a grantor retained annuity trust (GRAT) associated with him made a bona fide gift of 16,810 Oracle common shares. The same day, 128,304 shares were moved from his 2024 GRAT to the Henley Community Property Trust, which he views as a change in the form of beneficial ownership under Rule 16a-13.

After these moves, filings show 1,200,910 Oracle shares held indirectly by a trust and 490,333 shares held indirectly by the Henley Community Property Trust. The activity reflects estate and ownership structuring rather than open‑market buying or selling.

Oracle Corp Chief Executive Officer Clayton M. Magouyrk reported an open-market sale of 10,000 shares of Oracle common stock. The transaction occurred on February 9, 2026 at a weighted average price of $155.2318 per share, based on multiple trades between $155.23 and $155.28.

After this sale, Magouyrk directly owns 134,030 Oracle shares. The filing notes that detailed trade-by-trade price and share information is available upon request to Oracle, the SEC staff, or any Oracle shareholder.

Oracle Corporation executive Stuart Levey reported a routine equity accrual related to his compensation. On 01/23/2026, he received 337.783 restricted stock units as an "A"-coded acquisition. These units represent dividend equivalents accrued on earned restricted stock units originally granted on November 5, 2022, which he has elected to defer. The number of dividend equivalents was calculated using Oracle's closing stock price of $177.16 on the dividend payment date. Following this transaction, Levey beneficially owns 159,494.982 derivative securities in the form of restricted stock units, held directly.

Oracle Corp executive Douglas A. Kehring, EVP and Principal Financial Officer, reported selling 35,000 shares of Oracle common stock on January 15, 2026 at a price of $194.89 per share. The sale was made pursuant to a Rule 10b5-1 trading plan that was adopted on October 9, 2025, which allows pre-arranged trading according to preset terms.

Following this transaction, Kehring reports 33,638 shares of Oracle common stock held directly. He also reports an additional 2,157.514 units of Oracle common stock indirectly through the company’s 401(k) plan, where his interest is represented by units in a common stock fund rather than individual shares.

Oracle Corp executive Mark Hura reported two recent transactions in Oracle stock. On 12/22/2025, he made a bona fide gift of 5,000 shares of common stock to a donor advisory fund. Following that gift, he held 249,077 shares directly. On 12/24/2025, he sold 15,000 shares of Oracle common stock in open-market trades at a weighted average price of $196.8876 per share, with individual trades ranging from $196.87 to $196.93. After this sale, he directly owned 234,077 Oracle shares. Hura is identified as an officer of Oracle, serving as President, Global Field Operations.

Oracle Corporation insider Jeffrey Henley, a director and Vice Chairman, reported a change in how he holds some of his Oracle common stock. On December 23, 2025, he transferred 199,071 shares of common stock from his family trust to the Jeffrey & Judy Henley 1989 Trust. The filing states that he believes this transfer is a change in the form of beneficial ownership that is exempt under Rule 16a-13 of the Securities Exchange Act of 1934.

After the transaction, Henley reported indirect beneficial ownership of 1,200,910 shares by trust, 145,114 shares by a GRAT, and 362,029 shares by the Henley Community Property Trust. The reported transaction price is listed as $0, reflecting that this was a restructuring of ownership between related trusts rather than an open-market trade.

Oracle Corp director Naomi O. Seligman reported selling 2,223 shares of Oracle common stock at a price of $196.61 per share on 12/23/2025. After this transaction, she beneficially owned 25,596 shares directly, 6,000 shares indirectly through her spouse, and 14,414 shares indirectly through a trust. The filing indicates this was a routine insider transaction reported by a single reporting person.

Oracle Corp's chief executive officer, Clayton M. Magouyrk, reported a sale of company stock. On 12/19/2025, he sold 10,000 shares of Oracle common stock in an open market transaction at a weighted average price of $192.5152 per share. The filing notes that the trade was executed in multiple transactions at prices ranging from $192.48 to $192.625, with the reported price reflecting the weighted average.

Following this sale, Magouyrk beneficially owned 144,030 shares of Oracle common stock in direct ownership. The reporting person has undertaken to provide full trade details, including the number of shares and specific prices for each trade, to the SEC staff, Oracle, or any Oracle security holder upon request.

Oracle Corporation executive Maria Smith, EVP and Chief Accounting Officer, reported equity transactions in Oracle common stock. On 12/05/2025, 11,016 shares were acquired at an exercise or conversion price of $0 through the vesting and settlement of restricted stock units, increasing her directly held shares. On the same date, 5,740 shares were disposed of at $214.33 per share to cover tax withholding obligations related to the vesting. After these transactions, Smith directly beneficially owned 52,359 shares of Oracle common stock.

Oracle Corporation (ORCL) director Stephen Rusckowski reported an equity award in the form of restricted stock units. On 11/18/2025, he received 793 restricted stock units, each representing the right to receive one share of Oracle common stock at settlement. The filing shows these derivative securities as owned directly, with an exercise price of $0.

The restricted stock units are scheduled to vest 100% on the first anniversary of the grant date, meaning all 793 units vest together after one year. This is a routine director equity grant intended to align the director’s interests with those of shareholders over time.

Oracle (ORCL) director reported insider sales. On 10/28/2025, The Berg Family Trust executed multiple sales of Oracle common stock: 9,042, 13,373, 22,724, and 4,226 shares at weighted-average prices of $281.579, $282.555, $283.627, and $284.307, respectively.

Following these transactions, 151,999 shares were beneficially owned indirectly by The Berg Family Trust, and 5,000 shares were held indirectly by the spouse.

Oracle Corp (ORCL) executive Douglas Kehring (EVP, Principal Financial Officer) reported an equity award. On 10/23/2025, he received 60,700 restricted stock units (RSUs), shown at a price of $0 as customary for awards. Each RSU represents the right to receive one share of common stock at settlement.

The RSUs vest in four equal annual installments, beginning on the first anniversary of the grant date. Following this grant, 60,700 derivative securities were beneficially owned on a direct basis.

Oracle Corp (ORCL) insider Lawrence J. Ellison reported a stock option grant for 571,286 shares at an exercise price of $280.07 on October 23, 2025. The option expires on October 23, 2035 and vests 25% each year on the anniversary of the grant date. The filing lists Ellison as Director, Executive Chairman, Chief Technology Officer, and a 10% Owner, with ownership reported as Direct.

Oracle (ORCL) Form 4: Company officer Mark Hura, Pres., Global Field Operations, reported a grant of stock options on 10/23/2025. The award covers 428,465 options with an exercise price of $280.07 per share and an expiration date of 10/23/2035.

Following the grant, 428,465 derivative securities are beneficially owned, held directly. The options vest 25% each year on the anniversary of the grant date.

Oracle (ORCL) reported an insider equity award: Vice Chairman and Director Jeffrey Henley received 32,135 restricted stock units on 10/23/2025, as shown on a Form 4. Each RSU represents the right to receive one share of common stock at settlement.

The RSUs vest in four equal annual installments, beginning on the first anniversary of the grant date. The filing lists the award as Direct (D) ownership.

Oracle Corp (ORCL) filed a Form 4 for CEO and Director Safra Catz detailing an equity award. On 10/23/2025, Catz was granted 32,135 restricted stock units.

Each RSU represents the right to receive one share of Oracle common stock at settlement. The RSUs vest in four equal annual installments, beginning on the first anniversary of the grant date. Following the reported transaction, 32,135 derivative securities were beneficially owned, with ownership reported as direct.

Oracle Corp (ORCL) executive Maria Smith, EVP and Chief Accounting Officer, reported an equity award on a Form 4. On 10/23/2025, she was granted 35,706 restricted stock units (RSUs) (Transaction Code: A) at a price of $0.

Each RSU represents the right to receive one share of common stock at settlement. The RSUs vest in four equal annual installments, beginning on the first anniversary of the grant date. Following the reported transaction, 35,706 derivative securities were beneficially owned directly.

Oracle (ORCL): EVP and Chief Legal Officer reported equity awards. On 10/23/2025, the reporting person acquired 49,988 restricted stock units (RSUs) at a $0 price, which vest in four equal annual installments beginning on the first anniversary of the grant. The filing also records 142.94 dividend equivalents accrued on earned RSUs granted on 11/05/2022, calculated using Oracle’s closing price of $280.07 on 10/23/2025, the dividend payment date.

Following these transactions, direct derivative holdings reported were 159,157.199 after the dividend-equivalent entry and 49,988 for the new RSU grant. Each RSU represents the right to receive one share of common stock at settlement.

Oracle (ORCL) executive Maria Smith, EVP and Chief Accounting Officer, reported sales of 10,000 shares of Oracle common stock. The transactions included 5,000 shares at $280.00 on October 21, 2025 and 5,000 shares at a weighted‑average price of $280.6245 on October 23, 2025.

After these sales, she beneficially owns 47,083 shares directly. The filing notes the second trade was executed in multiple transactions within the stated price range; the weighted average price is reported.

Oracle Corp (ORCL) insider filing: the Chief Executive Officer reported an open-market sale (Transaction Code S) of 40,000 shares on 10/21/2025 at a weighted average price of $276.6377. The filing notes the sale was executed in multiple trades priced between $276.60 and $276.91.

Following this transaction, the reporting person beneficially owned 154,030 shares on a direct basis.

Oracle (ORCL) reported an insider transaction on a Form 4. On 10/10/2025, an officer (EVP, Chief Legal Officer) sold 19,758 shares of common stock at $300 per share, coded “S.” Following the sale, the officer beneficially owned 18,429 shares, held directly. The filing notes the sale was made under a Rule 10b5-1 trading plan adopted on July 10, 2025.

Naomi O. Seligman, a director of Oracle Corporation (ORCL), reported transactions in Oracle common stock on 09/26/2025. The filing shows a sale of 2,222 shares at $288.91 (transaction code S), followed the same day by a gift of 1,406 shares (transaction code G) with no cash consideration. After those transactions the reporting person is shown as directly owning 29,225 shares following the sale and 27,819 shares following the gift. The filing discloses 6,000 shares held indirectly by spouse and 14,414 shares held indirectly by a trust. An administrative correction notes 10 shares were previously overreported. The Form 4 is signed by attorney-in-fact Aimee Weast on behalf of Ms. Seligman.